Status:
UNKNOWN
Non Invasive Assessment of Heart Failure
Lead Sponsor:
Assiut University
Conditions:
Heart Failure
Eligibility:
All Genders
18-75 years
Phase:
EARLY_PHASE1
Brief Summary
1. To Identify the role of aldosterone antagonist in patients of heart failure with preserved ejection fraction. 2. Portray the health profile of heart failure patients admitted in internal medicine d...
Detailed Description
Heart failure (HF) is a growing epidemic related to significant morbidity and mortality. The prevalence of the disease continuously increases due to the ageing population and success in treating card...
Eligibility Criteria
Inclusion
- clinical diagnosed heart failure dyspnea grade III or IV
- Heart failure with ejecton fraction ≤40
Exclusion
- Acute coronary syndrome.
- Active infection
- Chronic kidney diseased patients
- Conn's disease
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04078425
Start Date
March 1 2020
End Date
May 1 2022
Last Update
January 9 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.